
Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 19, 2024, titled "Press Release regarding Change in Directorate".
Filed with NSE ·

Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 19, 2024, titled "Press Release regarding Change in Directorate".
6ix hasn’t read this filing yet.
Cohance Lifesciences Ltd on 6ix
Follow Cohance Lifesciences into a list and get an email when it puts out news.
Follow Cohance Lifesciences